Today we’re going to talk about helping patients with their rehabilitation through exoskeletons and even humanoid robots.

Founded in 2015, our guest for today Fourier Intelligence aims to redefine rehabilitation robotics solutions by integrating inter-connectable intelligent robotics technology with creativity. 

So far, the firm provides over 30 products and 200 solutions that can assist patients with upper and lower body impairments, as well as those with difficulties with movements and balance. 

Why are we speaking to Fourier Intelligence you might ask? Well, it may be early days for robots in the rehabilitation industry now, but the space holds tremendous potential. 

For one thing, Grand View Research valued the global rehabilitation robots market at US$226 million in 2021. It also expects the market to grow at a compound annual growth rate of 17.3% from 2022 to 2030 amid a rise in healthcare spending and an ageing population in maturing economies. So what are the opportunities ahead for Fourier Intelligence? 

Meanwhile, the firm is also building a network of researchers to chart the new frontier of innovative medical technologies, with strategic partners such as the Shirley Ryan AbilityLab in Chicago, the National Healthcare Group in Singapore, and the University of Melbourne. What can we expect on this front?

And just to get you excited – Fourier Intelligence also debuted what’s said to be the world’s first general-purpose humanoid robot for use in rehabilitative care and scientific research. But what does the invention mean for the company?

On Under the Radar, The Evening Runway’s finance presenter Chua Tian Tian posed these questions to Zen Koh, Co-founder and Global CEO of Fourier Intelligence.

Today we’re going to talk about helping patients with their rehabilitation through exoskeletons and even humanoid robots.
Founded in 2015, our guest for today Fourier Intelligence aims to redefine rehabilitation robotics solutions by integrating inter-connectable intelligent robotics technology with creativity. 
So far, the firm provides over 30 products and 200 solutions that can assist patients with upper and lower body impairments, as well as those with difficulties with movements and balance. 
Why are we speaking to Fourier Intelligence you might ask? Well, it may be early days for robots in the rehabilitation industry now, but the space holds tremendous potential. 
For one thing, Grand View Research valued the global rehabilitation robots market at US$226 million in 2021. It also expects the market to grow at a compound annual growth rate of 17.3% from 2022 to 2030 amid a rise in healthcare spending and an ageing population in maturing economies. So what are the opportunities ahead for Fourier Intelligence? 
Meanwhile, the firm is also building a network of researchers to chart the new frontier of innovative medical technologies, with strategic partners such as the Shirley Ryan AbilityLab in Chicago, the National Healthcare Group in Singapore, and the University of Melbourne. What can we expect on this front?
And just to get you excited – Fourier Intelligence also debuted what’s said to be the world’s first general-purpose humanoid robot for use in rehabilitative care and scientific research. But what does the invention mean for the company?
On Under the Radar, The Evening Runway’s finance presenter Chua Tian Tian posed these questions to Zen Koh, Co-founder and Global CEO of Fourier Intelligence.

We speak with businesses, industry leaders, venture capitalists and startups on their assessment of the business environment they're in, and what the future holds for them.

We speak with businesses, industry leaders, venture capitalists and startups on their assessment of the business environment they're in, and what the future holds for them.

Advertisement